Insider trades
Randal W. Scott, Director of BridgeBio Pharma BBIO, has filed 0 purchases and 17 sales on the open market. Over the past 12 months that comes to a net sale of $2.1M. The latest trade was on 05/15.
Randal W. Scott
Director
- Company
- BridgeBio Pharma BBIO
- First filing
- 23/05/01
- Trades
- 31 trades
- Buys / sales
- 0 / 17
- 12-month net buying
- −$2.1M
- Last trade
- 05/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
BBIO | Open-market sale10b5-1 plan | 05/15 | 05/19 | 10,000 sh4 trades | $67.15avg. | $671,468.4 | −46.3% |
BBIO | Open-market sale10b5-1 plan | 02/17 | 02/18 | 10,000 sh3 trades | $75.46avg. | $754,553.52 | −46.3% |
BBIO | Open-market sale10b5-1 plan | 25/11/17 | 25/11/19 | 10,000 sh2 trades | $66.65avg. | $666,467.36 | −46.3% |
BBIO | Open-market sale10b5-1 plan | 24/06/03–24/06/04 | 24/06/05 | 2,500 sh3 trades | $30.32avg. | $75,790 | −38.5% |
BridgeBio PharmaBBIO | Open-market sale10b5-1 plan | 24/03/01 | 24/03/05 | 2,500 sh | $34.00 | $85,000 | −27.8% |
BridgeBio PharmaBBIO | Open-market sale10b5-1 plan | 23/12/18 | 23/12/20 | 2,000 sh | $40.00 | $80,000 | −18.2% |
BBIO | Open-market sale10b5-1 plan | 23/12/01 | 23/12/05 | 2,500 sh2 trades | $29.40avg. | $73,500 | −18.5% |
BridgeBio PharmaBBIO | Open-market sale10b5-1 plan | 23/09/05 | 23/09/07 | 2,500 sh | $30.00 | $75,000 | −15.6% |